PREVENCIO
Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease. The company's biomarkers employ artificial intelligence to interrogate well-characterized clinical data sets to produce novel, multi-protein, algorithmically-scored tests, enabling clinicians to assess pre-drug/post-drug effects on a composite of heart attack, stroke and cardiac death.
PREVENCIO
Industry:
Health Care Health Diagnostics Medical
Founded:
2013-05-14
Address:
Kirkland, Washington, United States
Country:
United States
Website Url:
http://www.prevenciomed.com
Total Employee:
1+
Status:
Active
Contact:
(425) 576-1200
Email Addresses:
rrhyne@prevenciomed.comkelsey@prevenciomed.com
support@prevenciomed.com
hart@prevenciomed.com
Total Funding:
10.98 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Font API Google Tag Manager Google Analytics Global Site Tag Google Analytics 4 Cloudflare JS CDN JS
Similar Organizations
Tarveda Therapeutics
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
FloBio
FloBio develops point-of-care diagnostics for bleeding risk based on real-time blood analysis.
Open Systems Healthcare
Open Systems Healthcare is a healthcare services firm that offers healthcare services to patients & children.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
SonALAsense
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
Thrive Earlier Detection
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Trice Medical
Trice Medical specializes in providing solutions for orthopedic diagnostics.
Current Advisors List
Board_member
Board_member
2013-08-12
Board_member
2014-01-01
Board_member
2012-05-14
Board_member
Advisor
2012-05-14
Current Employees Featured
Michele McCarthy Chief Financial Officer @ Prevencio
Chief Financial Officer
2020-06-01
Celine Peters VP, Clinical Market Development @ Prevencio
VP, Clinical Market Development
2018-01-01
Grady Barnes Chief Scientific Officer @ Prevencio
Chief Scientific Officer
2017-03-20
Craig Magaret Chief Analytics Officer @ Prevencio
Chief Analytics Officer
2013-11-01
Rhonda Rhyne Chief Executive Officer, President, Chief Translational Officer, and Board Director @ Prevencio
Chief Executive Officer, President, Chief Translational Officer, and Board Director
2013-08-01
Founder
Investors List
MedTech Innovator
MedTech Innovator investment in Non Equity Assistance - Prevencio
Official Site Inspections
http://www.prevenciomed.com
- Host name: 85.52.185.35.bc.googleusercontent.com
- IP address: 35.185.52.85
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Prevencio"
Meet Prevencio || Heart Blood Tests for Heart Disease
Rhonda Rhyne has spent the past 20 years in executive management for biotechnology and medical technology companies. She has served as Chief Executive Officer, Chief Translational Officer, and Board Director for …See details»
Prevencio - Crunchbase Company Profile & Funding
Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease. The company's biomarkers employ artificial intelligence to interrogate …See details»
Prevencio - LinkedIn
Specialties Health Care, Prevencio, Blood Tests For Cardiovascular Disease , Cardiovascular Disease , Artificial Intelligence, Heart Attack, Stroke, Diagnostic & Prognostic Tests, and AISee details»
Prevencio Company Profile 2024: Valuation, Funding & Investors
Prevencio General Information Description. Developer of multi-proteomic biomarkers designed to transform blood tests for cardiovascular disease. The company's biomarkers employ artificial …See details»
Prevencio, Inc. - Company Profile & Staff Directory - ContactOut
Prevencio is Revolutionizing Blood Tests For Cardiovascular Disease || Powered by Artificial Intelligence (AI) || Preventative Medicine for Heart Health Prevencio's purpose is to prevent …See details»
Patient Info || Prevencio’s Blood Tests for Heart Health
HART CVE™ and HART CADhs™ received proprietary CPT PLA billing codes by the American Medical Association (AMA) in 2022. Effective January 1, 2023, the proprietary CPT PLA billing …See details»
Prevencio, Inc. | Kirkland, WA, US Startup - Gust
• Over the last 22 years Gary H. Frank has been directly involved with medical and other companies to strengthen and enable their business strategies by raising early stage capital, mezzanine and second round financing, and by …See details»
Prevencio | VentureRadar
Prevencio Med is dedicated to preventing cardiovascular diseases through innovative blood tests. Utilizing patented, proprietary technology,... ... Find out more ...See details»
Prevencio Develops Highly Accurate, Artificial Intelligence-driven ...
Sep 17, 2020 The company is headquartered in Kirkland, Washington. For additional information, visit www.PrevencioMed.com. Forward-Looking (Safe Harbor) Statement:See details»
Revolutionizing biomarker blood tests using artificial intelligence
Www.prevenciomed.com Revolutionizing biomarker blood tests using artificial intelligence By combining machine learning with multiple proteins and proprietary algorithms, Prevencio has …See details»
Prevencio Announces Laboratory Commercialization Partnership …
Apr 21, 2021 www.PrevencioMed.com. About Atlas Genomics: ATLAS Genomics is a CLIA-certified high complexity molecular diagnostic laboratory located in Seattle, WA. Its mission is …See details»
What's New at Prevencio || Prevencio Med
Nov 8, 2022 If this is something you would like to add to your office, contact Kelsey at kelsey@prevenciomed.com. CASE OF THE MONTH. Demographics: 69-year-old, 5’11”, 175 …See details»
Prevencio Announces U.S. Patent Issuance for Novel, Artificial ...
Aug 4, 2021 KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc. today announces the United States Patent Office’s issuance of a patent for its highly accurate blood test, HART …See details»
Prevencio’s AI-driven HART CVE Blood Test ... - Inter Press Service
Oct 4, 2021 Veteran’s Administration Data Highlighted at 2021 International Spinal Cord Society Scientific Sessions. KIRKLAND, WA — Prevencio, Inc. today announces the presentation of …See details»
Info for Healthcare Professionals on Prevencio’s Blood Tests
To assist you with the next steps or reach us directly at support@prevenciomed.com. Clinical Evidence. HART KD. HART CADhs. HART CVE HART paD. HART aS. HART aki. We …See details»
Prevencio Announces Highly Accurate, AI-driven Blood Test with …
Nov 19, 2019 KIRKLAND, Wash.--(BUSINESS WIRE)--Prevencio, Inc. today announces data confirming the high accuracy of its AI-driven, multiple-protein HART CADhs test, a biomarker …See details»
Prevencio | Top Medtech Startup-2021 - Medicaltechoutlook
Prevencio, Startups Solutions/Service Company, Kirkland, WA - Prevencio: The New-Age Cardio Vascular Diagnosis - Prevencio’s novel, AI-driven HART blood test utilizes machine...See details»
Our Heart Tests || Prevencio’s Blood Tests for Heart Health
HART CADhs™ provides clinical use in baselining and monitoring patients with known and unknown cardiovascular disease, patients with a history of typical or atypical cardiovascular …See details»
In the Press || Prevencio Blood Tests in Medical Journals
Media, please reach out to us at HART@prevenciomed.com for any press inquiries. Awards. read more > Top Med-Tech Award. read more > Top Heart Award. read more > Top …See details»